USD 1.60 billion
Hemostasis Products Market Size, Share, Growth Analysis, By Product(Topical Hemostasis Products, Infusible Hemostasis Products, Advanced Hemostasis Products), By Application(Trauma, Surgery, Hemophilia, Myocardial Infarction), By End-user(Hospitals, Clinics, and Others), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35A2702 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|Tables:
91
|Figures:
76
Hemostasis Products Market Insights
Hemostasis Products Market size was valued at USD 1.69 Billion in 2023 and is poised to grow from USD 1.78 Billion in 2024 to USD 2.73 Billion by 2032, growing at a CAGR of 5.5% during the forecast period (2025-2032).
The global hemostasis products market is witnessing steady growth due to increasing awareness and advancements in medical technology. These products play a crucial role in controlling bleeding during surgical procedures, trauma cases, and in managing various bleeding disorders. A growing aging population, coupled with a rise in chronic diseases and surgeries, is driving the demand for hemostasis products.
Additionally, the expanding availability of healthcare infrastructure in developing regions is contributing to market growth. Furthermore, ongoing research and development efforts are leading to the introduction of innovative hemostasis products, enhancing their efficiency and safety.
However, regulatory challenges and the high cost associated with these products can pose constraints to market expansion. Despite these challenges, the global hemostasis products market is poised for continued development as healthcare standards and technologies advance.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Surgery
Fastest Growth
Surgery
Growth Rate
5.5% CAGR
Global Hemostasis Products Market ($ Bn)
Country Share for NORTH AMERICA Region (%)
To get more reports on the above market click here to Buy The Report
Hemostasis Products Market Segmental Analysis
The global hemostasis products market is segmented on the basis of product, application, end-user, and region. Based on product, the market is segmented as Topical Hemostasis Product, Infusible Hemostasis Products, and Advanced Hemostasis Products. On the basis of application, the market is segmented into Trauma, Surgery, Hemophilia, Myocardial Infarction. Based on the end-user, it is segregated into hospitals, clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis by Product
Topical hemostasis products have historically been the dominating segment in the hemostasis products market. They are widely used for their ease of application and effectiveness in controlling bleeding in various medical procedures, including surgeries and dental work. While they continue to maintain a significant market share, their growth rate may be relatively stable due to their well-established position.
However, Infusible hemostasis products are experiencing robust growth within the market. This growth can be attributed to the increasing prevalence of bleeding disorders, such as hemophilia, and the rising adoption of hemostasis management techniques that require intravenous delivery. Advances in biotechnology and the development of new infusion therapies are driving the expansion of this segment.
Analysis by Application
Surgery is the dominating application within the hemostasis products market. This dominance can be attributed to the consistent demand for these products in various surgical procedures, including general, cardiovascular, orthopedic, and neurosurgery. Surgeons rely on hemostasis products to control bleeding and ensure patient safety during operations, making it a pivotal segment within the market.
However, the fastest-growing application in the hemostasis products market is trauma. This growth is primarily driven by the increasing incidence of accidents, injuries, and emergency cases worldwide.
Hemostasis merchandise are vital in trauma care to govern immoderate bleeding hastily, saving lives in vital conditions. Advances in trauma care protocols and stepped forward accessibility to healthcare services make contributions to the speedy enlargement of this segment.
Global Hemostasis Products market by Application
To get detailed analysis on other segments, Request For Free Sample Report
Hemostasis Products Market Regional Insights
North America currently dominates the global hemostasis products market. This dominance can be attributed to well-established healthcare infrastructure, a high prevalence of surgical procedures, and a growing elderly population.The region also benefits from significant research and development investments, driving innovation in hemostasis products.
However, the Asia Pacific is the fastest-developing location inside the international hemostasis merchandise market. The increase is fueled with the aid of factors including increasing healthcare expenditure, growing cognizance about bleeding disorders, and increasing right of entry to healthcare offerings in rising economies. Additionally, a surge in surgical tactics and a growing middle-elegance population looking for advanced healthcare make contributions to the fast growth of the marketplace in this area.
Global Hemostasis Products market by Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Hemostasis Products Market Dynamics
Drivers
Advancements in Medical Technology
- Innovations such as the improvement of extra green and safer hemostasis products, along with hemostatic agents and gadgets, are substantially improving the remedy of bleeding issues and surgical procedures. These improvements improve patient consequences and pressure market increase.
Restraints
High Cost of Hemostasis Products:
- An outstanding restraint within the marketplace is the excessive cost associated with hemostasis merchandise. These merchandise may be pricey, making them much less accessible to healthcare centers with confined budgets and patients in a few regions. The fee element can hinder the considerable adoption of superior hemostasis answers, proscribing their market penetration and doubtlessly affecting affected person care.
Request Free Customization of this report to help us to meet your business objectives.
Hemostasis Products Market Competitive Landscape
In the enormously competitive global hemostasis products marketplace, numerous organizations are vying for market percentage. These gamers are engaged in strategic projects which include product innovation, collaborations, and mergers and acquisitions to bolster their positions. The marketplace's competitiveness is driven through the consistent pursuit of novel technology and answers to cope with bleeding disorders and decorate surgical results.
Additionally, businesses are focusing on increasing their international reach through establishing a strong distribution network and partnerships with healthcare establishments. The competitive panorama of the market continues to conform, with corporations searching to distinguish themselves through first-rate, efficacy, and cost-effectiveness in their hemostasis merchandise.
Top Player’s Company Profiles
- Johnson & Johnson (US)
- Pfizer (US)
- Baxter International (US)
- Medtronic (US)
- B. Braun Melsungen AG (Germany)
- Becton, Dickinson, and Company (BD) (US)
- Tricol Biomedical (US)
- Hemostasis LLC (US)
- CuraMedical BV (Netherlands)
- Teleflex Incorporated (US)
- CryoLife, Inc. (US)
- Ethicon, Inc. (US)
- Grifols, S.A. (Spain)
- Terumo Corporation (Japan)
- Integra LifeSciences Holdings Corporation (US)
- HemCon Medical Technologies, Inc. (US)
- Zimmer Biomet Holdings, Inc. (US)
- Haemonetics Corporation (US)
- CSL Behring LLC (Australia)
- Olympus Corporation (Japan)
Recent Developments
- In April 2024, Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology, announced its plan to sell hemostasis instruments and reagents to laboratories in the United States beginning in April, under the company's mutual OEM agreement with Siemens Healthineers.
- In November 2023, Ethicon, a Johnson & Johnson MedTech company, announced the approval of ETHIZIA™, an adjunctive hemostat solution which has been clinically proven to achieve sustained hemostasis in difficult to control bleeding situations.
- In March 2023, Werfen announced that it had successfully completed the acquisition of Immucor, Inc., after obtaining all necessary regulatory and antitrust approvals. The Transfusion and Transplant product lines complement Werfen's existing Hemostasis, Acute Care and Autoimmunity business lines, expanding its portfolio of Specialized Diagnostic solutions for hospitals and clinical laboratories.
Hemostasis Products Key Market Trends
- Growing Emphasis on Minimally Invasive Hemostasis Techniques: Healthcare companies and sufferers alike are searching for much less invasive strategies to manage bleeding issues and surgical techniques. This trend is using the development of progressive hemostasis merchandise and techniques that reduce tissue damage, reduce restoration time, and enhance usual affected person results. Minimally invasive hemostasis methods are becoming increasingly popular due to their potential for greater patient comfort and shorter hospital stays, which align with the broader healthcare industry's focus on value-based care.
Hemostasis Products Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to global hemostasis products market analysis, the market is characterized by steady growth driven by factors such as an aging population, a rise in chronic diseases, and the increasing prevalence of surgical procedures worldwide. Key players in the market continue to invest in research and development to introduce innovative products that enhance the efficiency and safety of hemostasis solutions.
However, challenges such as the high cost of these products and regulatory hurdles remain significant. North America dominates the market, while the Asia Pacific region is witnessing the fastest growth, primarily due to increasing healthcare expenditure and improving access to healthcare services.
Looking ahead, the global hemostasis products market is poised for continued expansion. Future growth will likely be propelled by advancements in medical technology, including the development of more sophisticated hemostatic agents and devices.
Additionally, the market will see increased adoption of minimally invasive hemostasis techniques, aligning with the healthcare industry's shift toward less invasive procedures. The ongoing expansion of healthcare infrastructure in emerging economies and a growing awareness of bleeding disorders will further contribute to market growth.
However, addressing cost-related concerns and navigating evolving regulatory landscapes will remain crucial for sustained success in this dynamic market.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 1.69 Billion |
| Market size value in 2032 | USD 2.73 Billion |
| Growth Rate | 5.5% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Hemostasis Products Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Hemostasis Products Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Hemostasis Products Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Hemostasis Products Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Hemostasis Products Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Hemostasis Products Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
